224 related articles for article (PubMed ID: 1327632)
21. The effect of carbenoxolone on the peripheral metabolism of cortisol in human patients.
Ulick S; Wang JZ; Hanukoglu A; Rösler A
J Lab Clin Med; 1993 Dec; 122(6):673-6. PubMed ID: 8245686
[TBL] [Abstract][Full Text] [Related]
22. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.
Walker BR; Yau JL; Brett LP; Seckl JR; Monder C; Williams BC; Edwards CR
Endocrinology; 1991 Dec; 129(6):3305-12. PubMed ID: 1954906
[TBL] [Abstract][Full Text] [Related]
23. Cellular selectivity of aldosterone action: role of 11 beta-hydroxysteroid dehydrogenase.
Benediktsson R; Walker BR; Edwards CR
Curr Opin Nephrol Hypertens; 1995 Jan; 4(1):41-6. PubMed ID: 7743156
[TBL] [Abstract][Full Text] [Related]
24. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
Ferrari P; Lovati E; Frey FJ
J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
[TBL] [Abstract][Full Text] [Related]
25. 11 beta-Hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity.
Yang K; Khalil MW; Strutt BJ; Killinger DW
J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):247-53. PubMed ID: 9191983
[TBL] [Abstract][Full Text] [Related]
26. Interconversion of cortisol and cortisone by 11beta-hydroxysteroid dehydrogenases type 1 and 2 in the perfused human placenta.
Sun K; Adamson SL; Yang K; Challis JR
Placenta; 1999 Jan; 20(1):13-9. PubMed ID: 9950140
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension.
Rauz S; Cheung CM; Wood PJ; Coca-Prados M; Walker EA; Murray PI; Stewart PM
QJM; 2003 Jul; 96(7):481-90. PubMed ID: 12881590
[TBL] [Abstract][Full Text] [Related]
28. Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol.
Andrew R; Smith K; Jones GC; Walker BR
J Clin Endocrinol Metab; 2002 Jan; 87(1):277-85. PubMed ID: 11788660
[TBL] [Abstract][Full Text] [Related]
29. Carbenoxolone does not cause a syndrome of mineralocorticoid excess in sheep.
Dodic M; May CN; Coghlan JP
Steroids; 1998 Feb; 63(2):99-104. PubMed ID: 9516720
[TBL] [Abstract][Full Text] [Related]
30. Is blood pressure commonly raised by moderate consumption of liquorice?
Sigurjonsdottir HA; Ragnarsson J; Franzson L; Sigurdsson G
J Hum Hypertens; 1995 May; 9(5):345-8. PubMed ID: 7623371
[TBL] [Abstract][Full Text] [Related]
31. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart PM; Corrie JE; Shackleton CH; Edwards CR
J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
[TBL] [Abstract][Full Text] [Related]
32. 11 beta-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy.
Walker BR; Williamson PM; Brown MA; Honour JW; Edwards CR; Whitworth JA
Hypertension; 1995 Apr; 25(4 Pt 1):626-30. PubMed ID: 7721407
[TBL] [Abstract][Full Text] [Related]
33. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I; Cutler GB
Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
[TBL] [Abstract][Full Text] [Related]
34. Congenital and acquired syndromes of apparent mineralocorticoid excess.
Edwards CR; Walker BR; Benediktsson R; Seckl JR
J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):1-5. PubMed ID: 8386930
[TBL] [Abstract][Full Text] [Related]
35. Cortisol-mediated potentiation of uterine artery contractility: effect of pregnancy.
Xiao D; Huang X; Bae S; Ducsay CA; Zhang L
Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H238-46. PubMed ID: 12063296
[TBL] [Abstract][Full Text] [Related]
36. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
[TBL] [Abstract][Full Text] [Related]
37. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
Rodríguez JA
Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
[TBL] [Abstract][Full Text] [Related]
38. Acute intrarenal administration of cortisol has no effect on renal blood flow in hypertensive individuals.
van Uum SH; Houben AJ; Hermus AR; Kroon AA; Walker BR; Sweep CG; Smits P; de Leeuw PW; Lenders JW
J Hypertens; 2002 Nov; 20(11):2275-83. PubMed ID: 12409967
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
Walker BR; Andrew R; MacLeod KM; Padfield PL
Clin Endocrinol (Oxf); 1998 Aug; 49(2):257-63. PubMed ID: 9828916
[TBL] [Abstract][Full Text] [Related]
40. [11 beta-hydroxysteroid-dehydrogenase: characteristics and the clinical significance of a key enzyme in cortisol metabolism].
Kerstens MN; Dullaart RP
Ned Tijdschr Geneeskd; 1999 Mar; 143(10):509-14. PubMed ID: 10321259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
